PF-03893787

DRUG2 trials

Sponsors

Pfizer

Conditions

AsthmaHealthy

Phase 1

A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

CompletedNCT00856687

Start: 2009-04-30End: 2009-12-31Target: 12Updated: 2010-01-22

A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers

CompletedNCT00992342

Start: 2009-11-30End: 2010-03-31Updated: 2010-03-18